<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"follicular":1,
"prognosis":3,
"survival":2,
"thyroid cancer":4,
"vascular invasion":1,
"calcium":1,
"hypocalcemia":1,
"hypoparathyroidism":1,
"parathyroid hormone":1,
"total thyroidectomy":1,
"Intervention":1,
"Orbit":1,
"Pediatrics":1,
"Technique":1,
"Tumor":1,
"aspiration cytology":1,
"cribriform adenocarcinoma":1,
"minor salivary gland":1,
"tongue":1,
"indocyanine green":1,
"near-infrared":1,
"surgery":2,
"technetium 99m–aggregated albumin":1,
"thyroid neoplasms":5,
"clinical audit":1,
"fine-needle aspiration":4,
"thyroid nodule":3,
"Myxofibrosarcoma":1,
"Sarcoma":1,
"Thyroid":9,
"follicular patterned lesion":1,
"noninvasive encapsulated follicular tumor":1,
"poorly differentiated thyroid carcinoma":1,
"preinvasive":1,
"head and neck":1,
"hoarseness":1,
"laryngeal osteosarcoma":1,
"odynophagia":1,
"thyroid cartilage":1,
"Double primary tumor":1,
"Intra-tumoral heterogeneity":1,
"Neoplasm metastasis":1,
"computed tomography":1,
"cytopathology":1,
"diagnosis":1,
"lung":1,
"neoplasm":1,
"delayed":1,
"observation":1,
"papillary":1,
"BRAF V600E":1,
"Immunohistochemistry":2,
"Low-grade papillary adenocarcinoma":1,
"Nasopharynx":1,
"Thyroid transcription factor-1":1,
"Aerobic glycolysis":2,
"Cancer":3,
"Fructose-1,6-bisphosphate":1,
"PFK":1,
"Central neck dissection":2,
"Lymph node metastasis":1,
"Papillary thyroid carcinoma":9,
"Thymosin beta 10":1,
"Conservative surgery":1,
"Pattern of recurrence":1,
"Risk-based treatment":1,
"Galectin-3":1,
"HBME-1":1,
"Thyroid nodules":3,
"Dimer":1,
"Pyruvate kinase M2":1,
"Tetramer":1,
"Tumor progression":1,
"Bethesda System for Reporting Thyroid Cytopathology (BSRTC)":1,
"atypia or follicular lesion of undetermined significance (AUS/FLUS)":1,
"thyroid cytopathology":1,
"Dosimetrical comparison":1,
"Head and neck cancer":1,
"IMRT":1,
"Volumetric arc techniques":1,
"congenital abnormalities":1,
"fetal thyroid function":1,
"iodine radioisotopes":1,
"maternal exposure":1,
"radiation effect":1,
"IgG4":1,
"carcinoma":3,
"thyroiditis":1,
"bone marrow failure":1,
"cancer predisposition":2,
"diamond Blackfan Anemia (DBA)":1,
"RAS mutation":1,
"follicular variant":1,
"oncocytic features":1,
"papillary carcinoma":3,
"BRAF mutation":1,
"liquid-based cytology":1,
"plump cells":1,
"thyroid carcinoma":5,
"thyroid lesions":1,
"Colorectal cancer":1,
"Protein tyrosine phosphatase":1,
"Agent Orange":1,
"Korea":1,
"cohort studies":1,
"dioxins":1,
"herbicides":1,
"mortality":2,
"veterans":1,
"(99m)TcO(4)(−) scintigraphy":1,
"Real-time PCR":1,
"Sodium-iodide symporter":1,
"Warthin's tumor":1,
"cytology":2,
"genetics":1,
"molecular diagnosis":1,
"Fukushima":1,
"Health impact":1,
"Morbidity risk":1,
"Mortality risk":1,
"Seasonal scenarios":1,
"Breast cancer":2,
"CDK1":1,
"CDK2":1,
"Tumor growth speed":1,
"Familial nonmedullary thyroid cancer":1,
"Screening":1,
"Susceptibility loci":1,
"Telomerase":1,
"miRNA":1,
"Anatomical sentinel lymph node biopsy":1,
"Feasibility":1,
"ACTH = adrenocorticotropic hormone":1,
"ADH = antidiuretic hormone":1,
"FSH = follicle stimulating hormone":1,
"FT3 = free triiodothyronine":1,
"FT4 = free thyroxine":1,
"GH = growth hormone":1,
"IGF-1 = insulin-like growth factor 1":1,
"IQR = interquartile range":1,
"LH = luteinizing hormone":1,
"PRL = prolactin":1,
"SITSH = syndrome of inappropriate TSH secretion":1,
"TRH = thyrotropin-releasing hormone":1,
"TSH = thyrotropin (thyroid stimulating hormone)":1,
"hyperthyroidism":3,
"pituitary surgery":1,
"somatostatin analogs":1,
"syndrome of inappropriate TSH secretion":1,
"thyrotropin-secreting pituitary adenoma":1,
"transsphenoidal surgery":1,
"Asthenia":1,
"Hand–foot syndrome":1,
"Hypertension":1,
"Mucositis":1,
"Side effects":1,
"Skin toxicity":1,
"Estrogen":1,
"FSH":1,
"LH":1,
"Progesterone":1,
"Hashimoto's thyroiditis":1,
"cellular immunity":1,
"thyroid gland":1,
"atrophic gastritis":1,
"autoimmune gastritis":1,
"iron deficiency anemia":1,
"pernicious anemia":1,
"type 1 gastric carcinoids":1,
"metastasis":2,
"outcome":1,
"cabozantinib":1,
"differentiated thyroid cancer":2,
"medullary thyroid cancer":1,
"sorafenib":2,
"tyrosine kinase inhibitors":1,
"vandetanib":1,
"Skin metastasis":1,
"Thyroid cancer, papillary":1,
"contrast-enhanced ultrasound":1,
"diagnostic performance":1,
"meta-analysis":2,
"Basic Helix-Loop-Helix Transcription Factor (bHLH)":1,
"E3 Ubiquitin Ligase":1,
"Pancreas":1,
"Pancreatic Cancer":1,
"Proteasome":1,
"Protein Degradation":1,
"Protein-Protein Interaction":1,
"Transcription Factor":1,
"Ubiquitylation (Ubiquitination)":1,
"Yeast Two-Hybrid":1,
"chemotherapy":2,
"long-term survival":1,
"malignant struma ovarii":1,
"breast carcinogenesis":1,
"cell proliferation":1,
"hepatoma upregulated protein expression":1,
"FOXP3":1,
"polymorphism":1,
"colloid":1,
"echogenic focus":1,
"Thyrotropin":1,
"Endoscopes":1,
"Keloid":1,
"Wound healing":1,
"fertility preservation":1,
"oocyte":1,
"perinatal outcome":1,
"vitrification":1,
"Akt":1,
"Anaplastic thyroid carcinoma":2,
"E-cadherin":1,
"Epithelial–mesenchymal transition":1,
"Herbimycin A":1,
"p53":1,
"CUSUM":1,
"Gasless endoscopic thyroidectomy":1,
"Learning curve":1,
"Parathyroids autotransplantation":1,
"Car/Pxr nuclear receptors":1,
"Mode of action":1,
"Mouse thyroid carcinogen":1,
"Threshold carcinogen":1,
"Thyroid follicular cell proliferation":1,
"Diagnostic yield":1,
"FNA":1,
"Ultrasound":1,
"Bone metastasis":1,
"Management":1,
"BRAF":1,
"RET/PTC1":1,
"recurrence":1,
"CD5":1,
"Carcinoma showing thymus-like differentiation":1,
"Hassall’s corpuscles":1,
"Radiotherapy":1,
"Thyroidectomy":2,
"thymic":1,
"adverse effects":1,
"lenvatinib":1,
"progression-free survival":1,
"targeted therapy":1,
"GSEA":1,
"LUSC":1,
"SPIA":1,
"TCGA":1,
"gene expression":1,
"signal transduction pathway":1,
"body mass index":1,
"cancer mortality":1,
"hospital nurses":1,
"kórházi nővérek":1,
"psychosomatic diseases":1,
"pszichoszomatikus betegségek":1,
"rákhalálozás":1,
"stress control":1,
"stresszkontroll":1,
"testtömegindex":1,
"Standard population":1,
"COX-2 expression":1,
"FNAB washouts":1,
"HT":1,
"PTC":1,
"MicroRNA":1,
"laryngeal squamous cell carcinoma":1,
"miR-9":1,
"prognostic biomarker":1,
"Thyroid tumors":1,
"neck lymph node dissection":1,
"Merkel cell":1,
"metastasis ovarian":1,
"neoplasms":1,
"Ki-67":1,
"adipocyte":1,
"lipoblast":1,
"Carcinoma of unknown primary":1,
"F-18 FDG PET/CT":1,
"metastases":1,
"treatment change":1,
"CBX7":1,
"Hürthle cell":1,
"Oncocytic lesions":1,
"Goitre epidemiology":1,
"Non-toxic goitre":1,
"Microcarcinoma":1,
"De novo mutation":1,
"Medullary thyroid carcinoma":2,
"Multiple endocrine neoplasia 2B":1,
"RET":1,
"Tandem mutations":1,
"Toxic nodule":1,
"Calcitonin":1,
"Lymph node metastases":1,
"US-guided fine-needle aspiration biopsy":1,
"Diabetes":1,
"Hepatitis C virus":1,
"Lymphoma":1,
"Mixed cryoglobulinemia":1,
"Carotid body tumor":1,
"differential diagnosis":1,
"imitation":1,
"Li-Fraumeni syndrome":1,
"children":1,
"hereditary paraganglioma-pheochromocytoma syndrome":1,
"whole-body MRI":1,
"High-dose I-131 ablation therapy":1,
"Predictive factor":1,
"Therapeutic failure":1,
"Thyroglobulin":1,
"TTF1":1,
"hormone receptors":1,
"mesonephric adenocarcinoma":1,
"ovary":1,
"uterus":1,
"Dosimetry":1,
"Iodine-124":1,
"Radioiodine therapy":1,
"Salivary gland":1,
"central lymph node metastasis":1,
"papillary thyroid microcarcinoma":1,
"thyroid neoplasm":1,
"ultrasonography":1,
"Insular":1,
"Poorly differentiated":1,
"Immunochemistry":1,
"Target therapy":1,
"Hepatocellular cancer":1,
"SEER":1,
"latency":1,
"second primary malignancy":1,
"Diffuse thyroid metastases":1,
"Renal cell cancer":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2014年12月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
